TipRanks
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Japanese Market
4569
KYORIN Pharmaceutical Co.,Ltd.
RESEARCH TOOLSreports
Want to see JP:4569 full AI Analyst Report?

KYORIN Pharmaceutical Co.,Ltd. (4569) Ratios

3 Followers

KYORIN Pharmaceutical Co.,Ltd. Ratios

JP:4569's free cash flow for Q1 2026 was ¥0.41. For the 2026 fiscal year, JP:4569's free cash flow was decreased by ¥ and operating cash flow was ¥0.03. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 5.18 4.60 3.88 2.62 3.40
Quick Ratio
 2.50 2.29 2.01 1.45 2.03
Cash Ratio
 0.54 0.40 0.43 0.31 0.55
Solvency Ratio
 0.14 0.15 0.24 0.21 0.17
Operating Cash Flow Ratio
 0.00 0.22 0.10 0.03 0.06
Short-Term Operating Cash Flow Coverage
 0.00 2.22 0.46 0.08 0.19
Net Current Asset Value
¥ 81.79B¥ 82.12B¥ 78.81B¥ 72.41B¥ 68.44B
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.12 0.15 0.12 0.12
Debt-to-Equity Ratio
 0.17 0.17 0.21 0.16 0.17
Debt-to-Capital Ratio
 0.14 0.14 0.17 0.14 0.15
Long-Term Debt-to-Capital Ratio
 0.13 0.13 0.13 <0.01 0.08
Financial Leverage Ratio
 1.34 1.37 1.42 1.36 1.40
Debt Service Coverage Ratio
 1.96 2.31 1.73 0.47 0.83
Interest Coverage Ratio
 8.70 14.04 72.53 94.45 77.62
Debt to Market Cap
 0.35 0.25 0.32 0.20 0.21
Interest Debt Per Share
 408.94 418.45 498.04 366.13 372.46
Net Debt to EBITDA
 1.40 1.46 0.78 0.62 0.17
Profitability Margins
Gross Profit Margin
40.21%40.88%45.75%43.01%44.29%
EBIT Margin
1.72%2.83%9.65%5.93%6.16%
EBITDA Margin
5.43%6.51%13.18%9.52%9.55%
Operating Profit Margin
1.72%2.83%9.65%5.22%4.52%
Pretax Profit Margin
2.32%3.53%9.82%6.06%6.10%
Net Profit Margin
1.73%2.73%6.98%4.58%4.17%
Continuous Operations Profit Margin
1.73%2.73%6.98%4.58%4.17%
Net Income Per EBT
74.64%77.47%71.15%75.63%68.39%
EBT Per EBIT
134.35%124.78%101.78%116.12%134.80%
Return on Assets (ROA)
1.15%1.76%4.69%3.08%2.68%
Return on Equity (ROE)
1.56%2.42%6.67%4.19%3.76%
Return on Capital Employed (ROCE)
1.32%2.15%7.92%4.72%3.63%
Return on Invested Capital (ROIC)
0.97%1.63%5.37%3.09%2.31%
Return on Tangible Assets
1.18%1.80%4.81%3.17%2.77%
Earnings Yield
3.31%3.65%10.53%5.29%4.84%
Efficiency Ratios
Receivables Turnover
 3.11 2.67 2.74 2.51 2.39
Payables Turnover
 6.43 5.17 4.55 4.78 4.59
Inventory Turnover
 1.12 1.10 1.07 1.27 1.31
Fixed Asset Turnover
 4.16 4.14 4.29 4.13 4.38
Asset Turnover
 0.67 0.65 0.67 0.67 0.64
Working Capital Turnover Ratio
 1.19 1.22 1.49 1.51 1.35
Cash Conversion Cycle
 387.01 397.60 393.09 355.71 350.61
Days of Sales Outstanding
 117.33 136.74 133.39 145.65 152.42
Days of Inventory Outstanding
 326.41 331.48 339.95 286.49 277.79
Days of Payables Outstanding
 56.73 70.61 80.25 76.43 79.60
Operating Cycle
 443.74 468.21 473.34 432.14 430.21
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 111.07 61.03 26.99 35.04
Free Cash Flow Per Share
 0.00 43.81 -38.14 -81.84 -129.09
CapEx Per Share
 0.00 67.26 99.17 108.84 164.13
Free Cash Flow to Operating Cash Flow
 0.00 0.39 -0.62 -3.03 -3.68
Dividend Paid and CapEx Coverage Ratio
 0.00 0.89 0.40 0.17 0.16
Capital Expenditure Coverage Ratio
 0.00 1.65 0.62 0.25 0.21
Operating Cash Flow Coverage Ratio
 0.00 0.27 0.12 0.07 0.09
Operating Cash Flow to Sales Ratio
 0.00 0.05 0.03 0.01 0.02
Free Cash Flow Yield
0.00%2.66%-2.54%-4.54%-7.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 30.37 27.41 9.50 18.91 20.67
Price-to-Sales (P/S) Ratio
 0.52 0.75 0.66 0.87 0.86
Price-to-Book (P/B) Ratio
 0.47 0.66 0.63 0.79 0.78
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 37.55 -39.38 -22.04 -13.20
Price-to-Operating Cash Flow Ratio
 0.00 14.81 24.61 66.84 48.63
Price-to-Earnings Growth (PEG) Ratio
 -0.38 -0.44 0.14 1.51 1.03
Price-to-Fair Value
 0.47 0.66 0.63 0.79 0.78
Enterprise Value Multiple
 11.07 12.95 5.81 9.72 9.21
Enterprise Value
 75.24B 106.48B 99.71B 110.59B 99.53B
EV to EBITDA
 11.03 12.95 5.81 9.72 9.21
EV to Sales
 0.60 0.84 0.77 0.93 0.88
EV to Free Cash Flow
 0.00 42.31 -45.51 -23.54 -13.46
EV to Operating Cash Flow
 0.00 16.69 28.44 71.39 49.57
Tangible Book Value Per Share
 2.37K 2.41K 2.29K 2.19K 2.10K
Shareholders’ Equity Per Share
 2.44K 2.48K 2.37K 2.28K 2.19K
Tax and Other Ratios
Effective Tax Rate
 0.25 0.23 0.29 0.24 0.32
Revenue Per Share
 2.19K 2.20K 2.26K 2.08K 1.98K
Net Income Per Share
 37.81 60.02 158.16 95.40 82.42
Tax Burden
 0.75 0.77 0.71 0.76 0.68
Interest Burden
 1.35 1.25 1.02 1.02 0.99
Research & Development to Revenue
 0.10 0.10 0.08 0.07 0.10
SG&A to Revenue
 0.23 0.38 0.28 0.27 0.26
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 1.85 0.39 0.29 0.29
Currency in JPY